REGN Filing
4Filing Date: Feb 11, 2026

REGENERON PHARMACEUTICALS, INC. (REGN) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001187443-26-000004open_in_new
Total Value$70.0K
Trades7
Insiders1

Transaction Details

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-10
Price$776.59
Total Value$7.8K
Shares Owned After17.89K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 10 shares of Company stock on February 9, 2026 at prices ranging from $776.04 to $776.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-57
Price$777.56
Total Value$44.3K
Shares Owned After17.84K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 57 shares of Company stock on February 9, 2026 at prices ranging from $777.02 to $777.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-5
Price$779.41
Total Value$3.9K
Shares Owned After17.82K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $779.13 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-2
Price$786.29
Total Value$1.6K
Shares Owned After17.80K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-12
Price$778.53
Total Value$9.3K
Shares Owned After17.82K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 12 shares of Company stock on February 9, 2026 at prices ranging from $778.11 to $778.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-1
Price$775.63
Total Value$775.63
Shares Owned After17.90K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-3
Price$783.34
Total Value$2.4K
Shares Owned After17.81K
Transaction DateFeb 9, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 3 shares of Company stock on February 9, 2026 at prices ranging from $783.20 to $783.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.

Post-Transaction Holdings

RYAN ARTHUR F
SecuritySharesChange
Common Stock17.89K-90 (-0.50%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-09 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: REGENERON PHARMACEUTICALS, INC. (REGN) CIK: 0000872589 --- Reporting Owner --- Name: RYAN ARTHUR F CIK: 0001187443 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $775.63 Total Value: $775.63 Shares Owned After: 17,902 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #2] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -10 | Price: $776.59 Total Value: $7,765.90 Shares Owned After: 17,892 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F2] Represents volume-weighted average price of sales of 10 shares of Company stock on February 9, 2026 at prices ranging from $776.04 to $776.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #3] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -57 | Price: $777.56 Total Value: $44,320.92 Shares Owned After: 17,835 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F3] Represents volume-weighted average price of sales of 57 shares of Company stock on February 9, 2026 at prices ranging from $777.02 to $777.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #4] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -12 | Price: $778.53 Total Value: $9,342.36 Shares Owned After: 17,823 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F4] Represents volume-weighted average price of sales of 12 shares of Company stock on February 9, 2026 at prices ranging from $778.11 to $778.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #5] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -5 | Price: $779.41 Total Value: $3,897.05 Shares Owned After: 17,818 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F5] Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $779.13 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #6] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $780.09 Total Value: $780.09 Shares Owned After: 17,817 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #7] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -5 | Price: $781.48 Total Value: $3,907.40 Shares Owned After: 17,812 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F6] Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $781.05 to $781.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #8] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $782.53 Total Value: $782.53 Shares Owned After: 17,811 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #9] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -3 | Price: $783.34 Total Value: $2,350.02 Shares Owned After: 17,808 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F7] Represents volume-weighted average price of sales of 3 shares of Company stock on February 9, 2026 at prices ranging from $783.20 to $783.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. [Transaction #10] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $784.59 Total Value: $784.59 Shares Owned After: 17,807 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #11] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $785.71 Total Value: $785.71 Shares Owned After: 17,806 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #12] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -2 | Price: $786.29 Total Value: $1,572.58 Shares Owned After: 17,804 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #13] Security: Common Stock Date: 2026-02-09 | Code: S (Open market sale) Shares: -1 | Price: $787.82 Total Value: $787.82 Shares Owned After: 17,803 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. --- Footnotes (Complete Index) --- F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. F2: Represents volume-weighted average price of sales of 10 shares of Company stock on February 9, 2026 at prices ranging from $776.04 to $776.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. F3: Represents volume-weighted average price of sales of 57 shares of Company stock on February 9, 2026 at prices ranging from $777.02 to $777.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. F4: Represents volume-weighted average price of sales of 12 shares of Company stock on February 9, 2026 at prices ranging from $778.11 to $778.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. F5: Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $779.13 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. F6: Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $781.05 to $781.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. F7: Represents volume-weighted average price of sales of 3 shares of Company stock on February 9, 2026 at prices ranging from $783.20 to $783.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. --- Signature --- /s/ /s/ Arthur F. Ryan (2026-02-11)

keid AI analysis is for reference only and does not constitute investment advice.